Here are the 10-Q quarterly reports from Scorpius Holdings Inc (SCPX) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow SCPX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SCPX filings page.
Scorpius Holdings, Inc. reported Q3 2025 results while disclosing that lenders have foreclosed on substantially all of its assets and that it now has no or nominal operations and assets. The asset sale closed for $16,253,147, leaving about $14.9 million of secured debt outstanding.
For the nine months ended September 30, 2025, revenue fell to $669,640 from $5,196,257 a year earlier, and net loss attributable to Scorpius was $15.8 million. Cash and cash equivalents were $581,608 and total stockholders’ deficit was $6.98 million, and management expresses substantial doubt about continuing as a going concern.
Scorpius Holdings, Inc. reports a steep contraction in its CDMO business and severe financial stress for the quarter ended June 30, 2025. Revenue fell to $227,534 from $759,944 a year earlier, while the six‑month total dropped to $439,798 from $4.27 million, reflecting loss of major customers. The company posted a six‑month net loss attributable to Scorpius of $14.8 million and an accumulated deficit of $302.0 million.
Balance sheet pressure is acute: cash and cash equivalents were only $520,518, total liabilities were $29.5 million, and stockholders’ equity swung to a $(7.9) million deficit. Scorpius is in default on its December 2024 secured convertible notes and 2025 non‑convertible promissory notes, both held by related and institutional investors, and management concludes there is substantial doubt about its ability to continue as a going concern.
After quarter‑end, secured lenders conducted a UCC foreclosure sale of assets securing the December 2024 notes, closing on the sale of key CDMO facility assets for $16.25 million. The company states that, following this sale, it has no or nominal operations and assets. Separately, its common stock was delisted from NYSE American and now trades on the OTC Markets Pink tier, though Scorpius remains an SEC‑reporting company.